| # | Title | Journal | Year | Citations |
|---|
| 1 | COVID-19 pathophysiology: A review | Clinical Immunology | 2020 | 1,414 |
| 2 | Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients | Clinical Immunology | 1999 | 1,325 |
| 3 | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China | Clinical Immunology | 2020 | 1,031 |
| 4 | Diagnostic Criteria for Primary Immunodeficiencies | Clinical Immunology | 1999 | 964 |
| 5 | Particulate air pollutants and asthma | Clinical Immunology | 2003 | 632 |
| 6 | Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases | Clinical Immunology | 2006 | 586 |
| 7 | First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells | Clinical Immunology | 2009 | 567 |
| 8 | C-reactive protein: Ligands, receptors and role in inflammation | Clinical Immunology | 2005 | 527 |
| 9 | The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer | Clinical Immunology | 2006 | 525 |
| 10 | COVID-19: Immunology and treatment options | Clinical Immunology | 2020 | 485 |
| 11 | The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells | Clinical Immunology | 2006 | 462 |
| 12 | Antimicrobial peptides: General overview and clinical implications in human health and disease | Clinical Immunology | 2010 | 461 |
| 13 | Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity | Clinical Immunology | 2008 | 457 |
| 14 | Cytometric bead array: a multiplexed assay platform with applications in various areas of biology | Clinical Immunology | 2004 | 443 |
| 15 | The effects of IL-6 on CD4 T cell responses | Clinical Immunology | 2009 | 442 |
| 16 | Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 | Clinical Immunology | 2008 | 441 |
| 17 | Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice | Clinical Immunology | 2004 | 439 |
| 18 | Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases | Clinical Immunology | 2020 | 426 |
| 19 | The Th17/Treg imbalance in patients with acute coronary syndrome | Clinical Immunology | 2008 | 415 |
| 20 | Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis | Clinical Immunology | 2008 | 400 |
| 21 | T cell subset-specific susceptibility to aging | Clinical Immunology | 2008 | 388 |
| 22 | Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies | Clinical Immunology | 2010 | 368 |
| 23 | BCG-induced trained immunity in NK cells: Role for non-specific protection to infection | Clinical Immunology | 2014 | 359 |
| 24 | The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction | Clinical Immunology | 2005 | 358 |
| 25 | The role of resistin as a regulator of inflammation: Implications for various human pathologies | Clinical Immunology | 2009 | 345 |
| 26 | Immunopathogenesis of osteoarthritis | Clinical Immunology | 2013 | 317 |
| 27 | CXCR3 and CCR5 Ligands in Rheumatoid Arthritis Synovium | Clinical Immunology | 2001 | 316 |
| 28 | Transient regulatory T-cells: A state attained by all activated human T-cells | Clinical Immunology | 2007 | 310 |
| 29 | Transfer of alopecia areata in the human scalp graft/Prkdcscid (SCID) mouse system is characterized by a TH1 response | Clinical Immunology | 2003 | 309 |
| 30 | Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up | Clinical Immunology | 2014 | 307 |
| 31 | Clinical, Immunological, and Molecular Analysis in a Large Cohort of Patients with X-Linked Agammaglobulinemia: An Italian Multicenter Study | Clinical Immunology | 2002 | 299 |
| 32 | Fibrosis of the Lung and Other Tissues: New Concepts in Pathogenesis and Treatment | Clinical Immunology | 2001 | 298 |
| 33 | 15d-PGJ2: The anti-inflammatory prostaglandin? | Clinical Immunology | 2005 | 298 |
| 34 | The innate immune response in ischemic acute kidney injury | Clinical Immunology | 2009 | 298 |
| 35 | Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications | Clinical Immunology | 2004 | 296 |
| 36 | Membrane complement regulatory proteins | Clinical Immunology | 2006 | 295 |
| 37 | Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: An Italian multicenter study | Clinical Immunology | 2008 | 293 |
| 38 | Natural killer cells in human health and disease | Clinical Immunology | 2006 | 280 |
| 39 | Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction | Clinical Immunology | 2010 | 268 |
| 40 | Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor | Clinical Immunology | 2009 | 267 |
| 41 | Mechanism of Action for Leflunomide in Rheumatoid Arthritis | Clinical Immunology | 1999 | 265 |
| 42 | A new CD21low B cell population in the peripheral blood of patients with SLE | Clinical Immunology | 2004 | 262 |
| 43 | Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients | Clinical Immunology | 2008 | 259 |
| 44 | TNFα blockade in human diseases: Mechanisms and future directions | Clinical Immunology | 2008 | 252 |
| 45 | The first case of COVID-19 treated with the complement C3 inhibitor AMY-101 | Clinical Immunology | 2020 | 252 |
| 46 | Peripheral blood dendritic cells and monocytes are differently regulated in the elderly | Clinical Immunology | 2007 | 251 |
| 47 | Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage | Clinical Immunology | 2001 | 250 |
| 48 | Adaptive immunity and atherosclerosis | Clinical Immunology | 2010 | 250 |
| 49 | Immune–microbiota interactions in health and disease | Clinical Immunology | 2015 | 245 |
| 50 | CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease | Clinical Immunology | 2007 | 241 |
